These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 33331516)

  • 1. Jules Bernard Luys: from a description of the subthalamic nucleus to hypnotism.
    Meira AT; ProdÓssimo AF; Froehner GS; Franklin GL; DE Meneses MS; Munhoz RP; Teive HAG
    Arq Neuropsiquiatr; 2020 Dec; 78(12):811-814. PubMed ID: 33331516
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Jules Bernard Luys: a singular figure of 19th century neurology.
    Parent A; Parent M; Leroux-Hugon V
    Can J Neurol Sci; 2002 Aug; 29(3):282-8. PubMed ID: 12195620
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Jules Bernard Luys in Charcot's penumbra.
    Parent M; Parent A
    Front Neurol Neurosci; 2011; 29():125-136. PubMed ID: 20938152
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The Luys' body].
    Bonduelle M; Cambier J
    Bull Acad Natl Med; 2003; 187(4):759-70. PubMed ID: 14556480
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Jules Bernard Luys and the subthalamic nucleus.
    Parent A
    Mov Disord; 2002 Jan; 17(1):181-5. PubMed ID: 11835459
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Subthalamic nucleus deep brain stimulation improves dyskinesias in Parkinson's disease beyond levodopa reduction.
    Mossner JM; Patil PG; Chou KL
    J Neural Transm (Vienna); 2019 Nov; 126(11):1479-1483. PubMed ID: 31494731
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Congress of Neurological Surgeons Systematic Review and Evidence-Based Guideline on Subthalamic Nucleus and Globus Pallidus Internus Deep Brain Stimulation for the Treatment of Patients With Parkinson's Disease: Executive Summary.
    Rughani A; Schwalb JM; Sidiropoulos C; Pilitsis J; Ramirez-Zamora A; Sweet JA; Mittal S; Espay AJ; Martinez JG; Abosch A; Eskandar E; Gross R; Alterman R; Hamani C
    Neurosurgery; 2018 Jun; 82(6):753-756. PubMed ID: 29538685
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improving outcomes of subthalamic nucleus deep brain stimulation in Parkinson's disease.
    Bari AA; Fasano A; Munhoz RP; Lozano AM
    Expert Rev Neurother; 2015 Oct; 15(10):1151-60. PubMed ID: 26377740
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Arachnophobia alleviated by subthalamic nucleus stimulation for Parkinson's disease.
    Allert N; Gippert SM; Sajonz BE; Nelles C; Bewernick B; Schlaepfer TE; Coenen VA
    J Neural Transm (Vienna); 2016 Jun; 123(6):631-5. PubMed ID: 27198699
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dyskinesia-inducing lead contacts optimize outcome of subthalamic stimulation in Parkinson's disease.
    Bouthour W; Béreau M; Kibleur A; Zacharia A; Tomkova Chaoui E; Fleury V; Benis D; Momjian S; Bally J; Lüscher C; Krack P; Burkhard PR
    Mov Disord; 2019 Nov; 34(11):1728-1734. PubMed ID: 31571277
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Deep brain stimulation of the subthalamic nucleus for control of extrapyramidal features in advanced idiopathic parkinson's disease: one year follow-up.
    Pinter MM; Alesch F; Murg M; Seiwald M; Helscher RJ; Binder H
    J Neural Transm (Vienna); 1999; 106(7-8):693-709. PubMed ID: 10907728
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Three-dimensional SPACE fluid-attenuated inversion recovery at 3 T to improve subthalamic nucleus lead placement for deep brain stimulation in Parkinson's disease: from preclinical to clinical studies.
    Senova S; Hosomi K; Gurruchaga JM; Gouello G; Ouerchefani N; Beaugendre Y; Lepetit H; Lefaucheur JP; Badin RA; Dauguet J; Jan C; Hantraye P; Brugières P; Palfi S
    J Neurosurg; 2016 Aug; 125(2):472-80. PubMed ID: 26745490
    [TBL] [Abstract][Full Text] [Related]  

  • 13. End of day dyskinesia in advanced Parkinson's disease can be eliminated by bilateral subthalamic nucleus or globus pallidus deep brain stimulation.
    Apetauerova D; Ryan RK; Ro SI; Arle J; Shils J; Papavassiliou E; Tarsy D
    Mov Disord; 2006 Aug; 21(8):1277-9. PubMed ID: 16637040
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Subthalamic nucleus versus globus pallidus bilateral deep brain stimulation for advanced Parkinson's disease (NSTAPS study): a randomised controlled trial.
    Odekerken VJ; van Laar T; Staal MJ; Mosch A; Hoffmann CF; Nijssen PC; Beute GN; van Vugt JP; Lenders MW; Contarino MF; Mink MS; Bour LJ; van den Munckhof P; Schmand BA; de Haan RJ; Schuurman PR; de Bie RM
    Lancet Neurol; 2013 Jan; 12(1):37-44. PubMed ID: 23168021
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stimulation sites in the subthalamic nucleus and clinical improvement in Parkinson's disease: a new approach for active contact localization.
    Garcia-Garcia D; Guridi J; Toledo JB; Alegre M; Obeso JA; Rodríguez-Oroz MC
    J Neurosurg; 2016 Nov; 125(5):1068-1079. PubMed ID: 26848922
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Does unilateral basal ganglia activity functionally influence the contralateral side? What we can learn from STN stimulation in patients with Parkinson's disease.
    Brun Y; Karachi C; Fernandez-Vidal S; Jodoin N; Grabli D; Bardinet E; Mallet L; Agid Y; Yelnik J; Welter ML
    J Neurophysiol; 2012 Sep; 108(6):1575-83. PubMed ID: 22745463
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chronic stimulation of the subthalamic nucleus increases daily on-time without dyskinesia in advanced Parkinson's disease.
    Portman AT; van Laar T; Staal MJ; Rutgers AW; Journee HL; Leenders KL
    Parkinsonism Relat Disord; 2006 Apr; 12(3):143-8. PubMed ID: 16460986
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transient disabling dyskinesias: a predictor of good outcome in subthalamic nucleus deep brain stimulation in Parkinson's disease.
    Gago MF; Rosas MJ; Linhares P; Ayres-Basto M; Sousa G; Vaz R
    Eur Neurol; 2009; 61(2):94-9. PubMed ID: 19039227
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Simultaneous low-frequency deep brain stimulation of the substantia nigra pars reticulata and high-frequency stimulation of the subthalamic nucleus to treat levodopa unresponsive freezing of gait in Parkinson's disease: A pilot study.
    Valldeoriola F; Muñoz E; Rumià J; Roldán P; Cámara A; Compta Y; Martí MJ; Tolosa E
    Parkinsonism Relat Disord; 2019 Mar; 60():153-157. PubMed ID: 30241951
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deep brain stimulation of the subthalamic nucleus in Parkinson's disease 2003-2013: Where are we another 10 years on?
    Alamri A; Ughratdar I; Samuel M; Ashkan K
    Br J Neurosurg; 2015 Jun; 29(3):319-28. PubMed ID: 25619979
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.